205 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Psoriasis" (205 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
2 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
3 Recruiting An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
4 Recruiting Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Biological: Etanercept;   Other: Placebo
5 Recruiting A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
6 Not yet recruiting TSO for Plaque Psoriasis
Condition: Plaque Psoriasis
Intervention: Biological: Trichuris Suis Ova
7 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
8 Recruiting Diabetes and Psoriasis
Conditions: Diabetes;   Psoriasis
Intervention: Other: PASI and HOMA index
9 Recruiting Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome;   Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
10 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
11 Recruiting Vascular Inflammation in Psoriasis - Extension Study
Conditions: Psoriasis;   Cardiovascular Disease
Intervention: Drug: Adalimumab
12 Recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
13 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
14 Recruiting A Study Evaluating The Efficacy And Safety oO CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: placebo;   Drug: CP-690,550
15 Recruiting A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Guselkumab;   Drug: Placebo for ustekinumab;   Drug: Placebo for guselkumab
16 Recruiting miRNAs and mRNAs in Psoriasis
Condition: Psoriasis
Intervention: Other: 4 mm punch biopsies
17 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
18 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
19 Recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
20 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years